Allopurinol Enhances the Contractile Response to Dobutamine and Exercise in Dogs With Pacing-Induced Heart Failure
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background —Superoxide (O 2 − ) generated by enhanced xanthine oxidase (XO) activity may contribute to the increased myocardial oxidative stress in heart failure (CHF). Because blocking XO with allopurinol augments myofilament Ca 2+ sensitivity in reperfusion injury and CHF, we hypothesized that it may improve adrenergic inotropic responsiveness in CHF. Methods and Results —We studied the effect of allopurinol on the contractile response to dobutamine and exercise in 7 chronically instrumented conscious dogs before and after producing CHF by rapid pacing. Left ventricular (LV) contractile performance was measured by the slopes of the LV end-systolic pressure-volume relation (E ES ) and stroke work–end-diastolic volume relation (M SW ). Before CHF, allopurinol produced no change in LV contractile performance and did not alter the response to dobutamine or exercise. After CHF, allopurinol produced significant ( P <0.05) increases in E ES (5.0±0.6 versus 3.3±0.6 mm Hg/mL) and M SW . Dobutamine and allopurinol produced greater increases in E ES (5.4±0.6 versus 7.4±0.6 mm Hg/mL) and M SW (60.1±7.4 versus 73.7±4.4 mm Hg) than did dobutamine alone. After allopurinol, dP/dt max , stroke volume, and M SW were higher during CHF exercise. LV diastolic pressures were lower during CHF exercise after allopurinol. Conclusions —Allopurinol has no discernable effects on LV contractile function or adrenergic responsiveness in normal, conscious animals. In pacing-induced CHF, however, allopurinol improves LV systolic function at rest and during adrenergic stimulation and exercise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly
Beckman, J. S., & Koppenol, W. H. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.5.c1424 · Cited by 5,513
Cited by
Oxidative stress and heart failure
Tsutsui, H., Kinugawa, S., & Matsushima, S. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00554.2011 · Cited by 1,231
Pacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
“Dog Pacing-induced HR Allopurinol Allopurinol had no effects on LV contractile function or adrenergic responsiveness in normal conscious animals; in pacing-induced CHF, allopurinol improved LV systolic function at rest and during adrenergic stimulation and exercise Ukai et al. (2001)”
BackgroundInfluentialBerry, C. E., & Hare, J. M. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055913 · Cited by 927
Treating Oxidative Stress in Heart Failure: Past, Present and Future
van der Pol, A., van Gilst, W. H., Voors, A. A., & van der Meer, P. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1320 · Cited by 813
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Takimoto, E., & Kass, D. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000254415.31362.a7 · Cited by 770
Uric acid and inflammatory markers
Ruggiero, C., Cherubini, A., Ble, A., Bos, A. J. G., Maggio, M., Dixit, V. D., Lauretani, F., Bandinelli, S., Senin, U., & Ferrucci, L. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi879 · Cited by 591
Increased myocardial NADPH oxidase activity in human heart failure
Heymes, C., Bendall, J. K., Ratajczak, P., Cave, A. C., Samuel, J.-L., Hasenfuss, G., & Shah, A. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00471-6 · Cited by 579
Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D. V., Reaveley, D. A., Schuler, G., Coats, A. J. S., Anker, S. D., & Hambrecht, R. (2002) · Circulation · doi:10.1161/01.cir.0000017502.58595.ed · Cited by 565
Carnes, C. A., Chung, M. K., Nakayama, T., Nakayama, H., Baliga, R. S., Piao, S., Kanderian, A., Pavia, S., Hamlin, R. L., McCarthy, P. M., et al. (2001) · Circulation Research · doi:10.1161/hh1801.097644 · Cited by 523
Uric acid and cardiovascular disease
Ndrepepa, G. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.05.046 · Cited by 498
Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated Cardiomyopathy
Cappola, T. P., Kass, D. A., Nelson, G. S., Berger, R. D., Rosas, G. O., Kobeissi, Z. A., Marbán, E., & Hare, J. M. (2001) · Circulation · doi:10.1161/hc4501.098928 · Cited by 436
Noman, A., Ang, D. S., Ogston, S., Lang, C. C., & Struthers, A. D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60391-1 · Cited by 348
NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure
MURDOCH, C., ZHANG, M., CAVE, A., & SHAH, A. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.016 · Cited by 343
Khan, S. A., Lee, K., Minhas, K. M., Gonzalez, D. R., Raju, S. V. Y., Tejani, A. D., Li, D., Berkowitz, D. E., & Hare, J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404136101 · Cited by 227
Saavedra, W. F., Paolocci, N., St. John, M. E., Skaf, M. W., Stewart, G. C., Xie, J.-S., Harrison, R. W., Zeichner, J., Mudrick, D., Marbán, E., et al. (2002) · Circulation Research · doi:10.1161/hh0302.104531 · Cited by 196
Diastolic mitral annular velocityduring the development of heart failure
Hasegawa, H., Little, W. C., Ohno, M., Brucks, S., Morimoto, A., Cheng, H.-J., & Cheng, C.-P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00260-2 · Cited by 185
“features of a dilated cardiomyopathy (16,17).”
MethodSelf-citationXanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated Cardiomyopathy
Minhas, K. M., Saraiva, R. M., Schuleri, K. H., Lehrke, S., Zheng, M., Saliaris, A. P., Berry, C. E., Vandegaer, K. M., Li, D., & Hare, J. M. (2006) · Circulation Research · doi:10.1161/01.res.0000200181.59551.71 · Cited by 170
Cardiovascular Drugs and Serum Uric Acid
Reyes, A. J. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/b:card.0000015855.02485.e3 · Cited by 164
“In dogs with pacing-induced heart failure, allopurinol raised myocardial efficiency [226] and improved systolic function at rest and the contractile response to dobutamine and exercise [227].”
BackgroundModerate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells
Kelley, E. E., Hock, T., Khoo, N. K. H., Richardson, G. R., Johnson, K. K., Powell, P. C., Giles, G. I., Agarwal, A., Lancaster, J. R., & Tarpey, M. M. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.11.008 · Cited by 93
Allopurinol, Xanthine Oxidase, and Cardiac Ischemia
Lee, B. E., Toledo, A. H., Anaya-Prado, R., Roach, R. R., & Toledo-Pereyra, L. H. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e3181bca50c · Cited by 46
Metadata
- Authors
- Ukai, T., Cheng, C.-P., Tachibana, H., Igawa, A., Zhang, Z.-S., Cheng, H.-J., & Little, W. C.
- Venue
- Circulation
- Published
- 2001-02-06
- Volume
- 103
- Issue
- 5
- Pages
- 750-755
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2025071415
- Cited by
- 115
- References
- 1
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.